LAPTM5, a protein, is preferentially expressed in immune cells (Berberich et al., 2020), and could interact with the Nedd4 family of ubiquitin ligases, which played an essential role in multiple tumor initiation and progression. Here, LAPTM5 is linked to neoplasm.